Ensured LMIC access to molnupiravir
Dr. Reddys Laboratories, a multinational pharmaceutical company, is expanding access to generic molnupiravir in low- and middle-income countries.
-
Domain
-
Investment typeVolume guarantee
-
StatusExit
-
Initial investmentPublic
-
Partnered in2022
-
Investment leadChris Chen
-
HeadquartersIndia
-
Program strategyCOVID-19 Response
More about our work
Our focus
Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.
Investment approach
Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.
Our team
We bring depth of experience to every investment, with a proven track record across sectors and scale.